CD4 T-cell immunotherapy for chronic viral infections and cancer.

CD4 T-cell immunotherapy for chronic viral infections and cancer.
复制标题

DOI:
10.2217/imt.13.91
复制
发表时间:
2013-09
期刊:
影响因子:
2.8
通讯作者:
Ahmed R
Ahmed R
中科院分区:
医学4区
文献类型:
--
作者:
Kamphorst AO;Ahmed R

文献摘要

参考文献

被引文献

相似文献

在慢性感染和癌症期间,T细胞逐渐失去功能并变得疲惫不堪。然而,有效的T细胞应答对于最终控制病毒感染和肿瘤是必要的。因此,需要探索通过过继免疫治疗恢复内源性免疫应答或提供功能性T细胞的策略。CD8 T细胞在病毒感染和癌症中起着重要作用,但CD4 T细胞是支持CD8 T细胞功能所必需的。此外,CD4 T细胞发挥直接效应功能,诱导最佳B细胞应答并协调先天免疫。因此,我们建议过继性转移策略应单独利用CD4 T细胞或与CD8 T细胞组合,用于治疗慢性感染和癌症。此外,由于过继转移的细胞会耗竭,因此过继转移疗法与抑制T细胞耗竭的免疫疗法相结合应使应答的寿命和成功率最大化。
During chronic infections and cancer, T cells progressively lose function and become exhausted. However, effective T-cell responses are necessary to ultimately control viral infections and tumors. Hence, strategies that either restore endogenous immune responses or provide functional T cells by adoptive immunotherapy need to be explored. CD8 T cells play a prominent role in viral infections, as well as cancer, but CD4 T cells are necessary to support CD8 T-cell function. In addition, CD4 T cells exert direct effector functions, induce optimal B-cell responses and orchestrate innate immunity. Therefore, we propose that adoptive transfer strategies should exploit CD4 T cells alone or in combination with CD8 T cells, for the treatment of chronic infections and cancer. Furthermore, since adoptively transferred cells are subject to exhaustion, combining adoptive transfer therapy with immunotherapies that inhibit T-cell exhaustion should maximize the longevity and success rate of responses.
DOI: 10.1038/ni.2180
发表时间: 2011-12-11
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Butler, Noah S.;Moebius, Jacqueline;Pewe, Lecia L.;Traore, Boubacar;Doumbo, Ogobara K.;Tygrett, Lorraine T.;Waldschmidt, Thomas J.;Crompton, Peter D.;Harty, John T.
通讯作者: Harty, John T.
DOI: 10.1172/jci32103
发表时间: 2008-01-01
影响因子: 15.9
作者:
Berger, Carolina;Jensen, Michael C.;Riddell, Stanley R.
通讯作者: Riddell, Stanley R.
DOI: 10.1084/jem.20101773
发表时间: 2011-05-09
期刊: The Journal of experimental medicine
影响因子: --
作者:
Fahey LM;Wilson EB;Elsaesser H;Fistonich CD;McGavern DB;Brooks DG
通讯作者: Brooks DG
DOI: 10.1038/nm.3109
发表时间: 2013-04
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1097/00002371-200307000-00005
发表时间: 2003-07-01
影响因子: 3.9
作者:
Dudley, ME;Wunderlich, JR;Rosenberg, SA
通讯作者: Rosenberg, SA